Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) FCF Margin (2017 - 2026)

Nutex Health (NUTX) has disclosed FCF Margin for 17 consecutive years, with 34.33% as the latest value for Q1 2026.

  • For Q1 2026, FCF Margin rose 1030.0% year-over-year to 34.33%; the TTM value through Mar 2026 reached 30.57%, up 1945.0%, while the annual FY2025 figure was 28.06%, 2372.0% up from the prior year.
  • FCF Margin hit 34.33% in Q1 2026 for Nutex Health, down from 45.48% in the prior quarter.
  • Across five years, FCF Margin topped out at 45.48% in Q4 2025 and bottomed at 46.46% in Q3 2022.
  • Average FCF Margin over 5 years is 11.36%, with a median of 10.86% recorded in 2025.
  • On a YoY basis, FCF Margin climbed as much as 6246bps in 2022 and fell as far as -11332bps in 2022.
  • Nutex Health's FCF Margin stood at 23.05% in 2022, then tumbled by -106bps to 1.36% in 2023, then skyrocketed by 90bps to 0.13% in 2024, then soared by 34457bps to 45.48% in 2025, then decreased by -25bps to 34.33% in 2026.
  • According to Business Quant data, FCF Margin over the past three periods came in at 34.33%, 45.48%, and 37.05% for Q1 2026, Q4 2025, and Q3 2025 respectively.